EUVIMEDOpdag EUVIMED
Multizentrische StudieOpen access · CC BY-NC-ND 4.0

Prognostic value of fetal growth and prenatal functional echocardiography in tetralogy of FALLOT

Laura Nogué iD, Mar Bennasar, Laura Guirado, Felix Zölner, Justus Reitz, Roland Axt-Fliedner, María C Escobar-Díaz, Josep Maria Martínez, Eduard Gratacós, Fàtima Crispi, Olga Gómez, BCNatal and Gießen and Marburg University investigators

Acta Obstetricia et Gynecologica Scandinavica · 2026

DOI: 10.1111/aogs.70137 ↗

At a glance

Multizentrische Studie in Acta Obstetricia et Gynecologica Scandinavica, 2026. Written by Laura Nogué and 11 co-authors. Institution: BCNatal Fetal Medicine Research Center (Hospital Clínic and Hospital Sant Joan de Déu), University of Barcelona, Barcelona, Spain. Major MEDLINE topics: Tetralogy of Fallot, Ultrasonography, Prenatal, Echocardiography, Fetal Development. 50 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Hospital Clínic de Barcelona, Instituto de Salud Carlos III, Fundació La Marató de TV3.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction

Tetralogy of Fallot (ToF) shows variability in neonatal outcomes, and identifying reliable prenatal predictors is essential for optimizing perinatal management. The aim of this study was to determine the prognostic value of feto‐placental data and prenatal echocardiography in the third trimester in ToF and to compare these findings with a matched control population. Material and Methods Multicenter prospective cohort study (2011–2023) at two referral centers (BCNatal and University Hospital of Gießen and Marburg). The cohort included 63 fetuses with isolated ToF and 66 healthy controls. All fetuses underwent a third trimester ultrasound and comprehensive echocardiography with 2D speckle tracking. Severe small‐for‐gestational age (SGA) was defined as estimated fetal weight (EFW) below the third percentile. Adverse composite outcomes were defined as the need for prostaglandin infusion, surgery or ductal stenting, corrective surgery before 3 months, and/or neonatal intensive care unit stay ≥7 days. The association of feto‐placental and cardiac data with adverse composite outcome was evaluated.

Results

Compared with controls, ToF fetuses showed higher rates of severe SGA (19% vs. 0%, p < 0.001). Cardiac findings showed mild biventricular concentric hypertrophy (relative wall thickness ToF 0.7 [0.5–0.9] vs. controls 0.5 [0.5–0.6], p = 0.001), and reduced deformation (right and left ventricular global longitudinal strain: ToF ‐17.3% ± 3.8 vs. controls −19.3% ± 3.1, p = 0.001; ToF ‐18.0% ± 3.8 vs. controls −20.9% ± 3.45, p < 0.001), regardless of placental dysfunction. The adverse composite outcome occurred in 29.3% of ToF cases with pulmonary stenosis. Within this group, EFW 70 cm/s when EFW was 144 cm/s when EFW was above the 3rd centile.

Conclusions

Combining EFW with PV artery Doppler may allow identification of a high‐risk subgroup of ToF‐PS fetuses who may benefit from closer prenatal monitoring and prompt neonatal care.

Subjects

MeSH terms (MEDLINE)

Tetralogy of FallotUltrasonography, PrenatalEchocardiographyFetal DevelopmentHumansFemalePregnancyProspective StudiesPrognosisAdultInfant, NewbornPregnancy Trimester, ThirdInfant, Small for Gestational AgeFetal Growth RetardationCase-Control Studies

Author keywords

2D speckle trackingcongenital heart diseasecord blood angiogenic factorsfetal echocardiographyfetal growth restrictionplacental dysfunctionstraintetralogy of Fallot

Authors and institutions

  • BCNatal Fetal Medicine Research Center (Hospital Clínic and Hospital Sant Joan de Déu), University of Barcelona, Barcelona, Spain.
  • Institut d'Investigacions Biomèdiques August pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Division of Perinatal Medicine and Fetal Therapy, Universitätsklinikum Gießen and Marburg, Gießen, Germany.
  • Pediatric Cardiology Department, Sant Joan de Déu Hospital, Esplugues de Llobregat, Barcelona, Spain.
  • Cardiovascular Research Group, Sant Joan de Deu Research Institute, Esplugues de Llobregat, Barcelona, Spain.
  • Centre for Biomedical Research on Rare Diseases (CIBER-ER), Madrid, Spain.

ORCID profiles: Laura Nogué

Funding

  • Hospital Clínic de Barcelona
  • Instituto de Salud Carlos III
  • Fundació La Marató de TV3
  • Departament de Recerca i Universitats de la Generalitat de Catalunya
  • Fundació Mutua Madrileña
  • Maternal and Child Health and Development Network (SAMID)
  • Departament de Recerca i Universitats, Generalitat de Catalunya

Cite

APA

Nogué, L., Bennasar, M., Guirado, L., Zölner, F., Reitz, J., Axt-Fliedner, R., Escobar-Díaz, M. C., Martínez, J. M., Gratacós, E., Crispi, F., Gómez, O., & BCNatal and Gießen and Marburg University investigators (2026). Prognostic value of fetal growth and prenatal functional echocardiography in tetralogy of FALLOT. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.70137

Vancouver

Nogué L, Bennasar M, Guirado L, Zölner F, Reitz J, Axt-Fliedner R, et al. Prognostic value of fetal growth and prenatal functional echocardiography in tetralogy of FALLOT. Acta Obstetricia et Gynecologica Scandinavica. 2026. doi:10.1111/aogs.70137

BibTeX
@article{Nogu2026,
  author = {Nogué, Laura and Bennasar, Mar and Guirado, Laura and Zölner, Felix and Reitz, Justus and Axt-Fliedner, Roland and Escobar-Díaz, María C and Martínez, Josep Maria and Gratacós, Eduard and Crispi, Fàtima and Gómez, Olga and BCNatal and Gießen and Marburg University investigators, BCNatal and Gießen and Marburg University investigators},
  title = {Prognostic value of fetal growth and prenatal functional echocardiography in tetralogy of FALLOT},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2026},
  doi = {10.1111/aogs.70137}
}
Start for free →